| Acquired by | Dainippon Sumitomo |
| Price | $2.6B |
| Date | 9/09 |
| Website | sepracor.com |
| Category | BioTech |
| Phone | 508-481-6700 |
| Employees | 2,400 |
| Founded | 1984 |
| Description | pharmaceutical company |
Sepracor Inc., a research-based pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceutical products.
The company’s suppliers include Catalent Pharma Solutions, LLC (Catalent); Holopack International Corporation (Holopack); and 3M.
The company has signed a technology license and development agreement with Arrow International Limited for know-how and intellectual property rights related to stable sterile steroid suspension formulations as well as other applicable nebule technology for the use in developing ciclesonide, a corticosteroid, in an inhalation solution. Sepracor, Inc. was founded in 1984.
